ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,265.10
0.30%
S&P ASX All Technology
3,780.50
-0.49%
Brent Oil
72.295
-0.03%
US Dollar vs AUD
1.5868
0.13%
Bitcoin
84,826.00
0.90%
Pepperstone
Advertisement
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX

  6. Palatin Technologies Inc New (PTN) Share Price

Palatin Technologies Inc New

Palatin Technologies Inc New (PTN)

Patronus Resources Ltd
Palatin Technologies Inc
Proton Capital Corp
0.9797
0.0592
(6.43%)
Closed 27 February 8:00AM
Delayed by 15 minutes
0.92
-0.0597
(-6.09%)
After Hours: 11:47AM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
0.92
Bid
-
Offer
-
Volume
270,835
0.90 Day's Range 0.97
0.68 52 Week Range 3.9929
Market Cap
23.925M
Previous Close
0.9205
Open
0.935
Last Trade
996
@
0.92
(formt)
Last Trade Time
Financial Volume
US$ 251,550
VWAP
0.928793
Average Volume (3m)
968,602
Shares Outstanding
26,005,846
Dividend Yield
-
PE Ratio
-0.85
Earnings Per Share (EPS)
-1.14
Revenue
4.49M
Net Profit
-29.74M

About Palatin Technologies Inc New

Palatin Technologies Inc is a part of the healthcare sector. The company is engaged in developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with unmet medical needs and commercial potential. Its programs are based on molecules that modulate the activity of the me... Palatin Technologies Inc is a part of the healthcare sector. The company is engaged in developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with unmet medical needs and commercial potential. Its programs are based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. Its main product in clinical development is bremelanotide, which treats hypoactive sexual desire disorder, which is a type of female sexual dysfunction. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
palatin.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Palatin Technologies Inc New is listed in the Pharmaceutical Preparations sector of the American Stock Exchange with ticker PTN. The last closing price for Palatin Technologies was US$0.92. Over the last year, Palatin Technologies shares have traded in a share price range of US$ 0.68 to US$ 3.9929.

Palatin Technologies currently has 26,005,846 shares in issue. The market capitalisation of Palatin Technologies is US$23.94 million. Palatin Technologies has a price to earnings ratio (PE ratio) of -0.85.

Ask ADVFN Intelligence (AI)

PTN Latest News

More News

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Edgar (US Regulatory)
15 February 2025
PTN (6.43%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
14 February 2025
PTN (6.43%)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Edgar (US Regulatory)
12 February 2025
PTN (6.43%)

Form 8-K - Current report
Edgar (US Regulatory)
11 February 2025
PTN (6.43%)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Edgar (US Regulatory)
11 February 2025
PTN (6.43%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.12-11.53846153851.041.05960.95544850.9820567CS
40.011.09890109890.911.380.7917781160.97900904CS
12-0.18-16.36363636361.11.450.71649686020.98906908CS
26-0.64-41.02564102561.561.720.685766371.01487695CS
52-2.19-70.41800643093.113.99290.684549231.39032565CS
1560.531136.5038560410.3898.60.18113772341.32429283CS
2600.3767.27272727270.558.60.181115564590.76291946CS

PTN - Frequently Asked Questions (FAQ)

What is the current Palatin Technologies share price?
The current share price of Palatin Technologies is US$ 0.92
How many Palatin Technologies shares are in issue?
Palatin Technologies has 26,005,846 shares in issue
What is the market cap of Palatin Technologies?
The market capitalisation of Palatin Technologies is USD 23.94M
What is the 1 year trading range for Palatin Technologies share price?
Palatin Technologies has traded in the range of US$ 0.68 to US$ 3.9929 during the past year
What is the PE ratio of Palatin Technologies?
The price to earnings ratio of Palatin Technologies is -0.85
What is the cash to sales ratio of Palatin Technologies?
The cash to sales ratio of Palatin Technologies is 5.62
What is the reporting currency for Palatin Technologies?
Palatin Technologies reports financial results in USD
What is the latest annual turnover for Palatin Technologies?
The latest annual turnover of Palatin Technologies is USD 4.49M
What is the latest annual profit for Palatin Technologies?
The latest annual profit of Palatin Technologies is USD -29.74M
What is the registered address of Palatin Technologies?
The registered address for Palatin Technologies is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Palatin Technologies website address?
The website address for Palatin Technologies is palatin.com
Which industry sector does Palatin Technologies operate in?
Palatin Technologies operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CHROChannel Therapeutics Corporation
US$ 2.23
(25.28%)
74.35k
SOARVolato Group Inc
US$ 2.53
(19.34%)
571.74k
PWPower REIT
US$ 1.25
(15.74%)
489.14k
ETQT Rex 2X Inverse Ether Daily Target ETF
US$ 15.56
(13.20%)
6.94k
MWGMulti Ways Holdings Limited
US$ 0.3501
(13.08%)
442.11k
AEONAEON Biopharma Inc
US$ 1.41
(-70.99%)
4.6M
ATCHAtlasClear Holdings Inc
US$ 2.82
(-26.18%)
18.92M
PHGEBiomX Inc
US$ 0.7917
(-14.93%)
427.15k
AMBOAmbow Education Holding Ltd
US$ 2.11
(-14.57%)
42.76k
SGNSigning Day Sports Inc
US$ 1.89
(-12.90%)
129.23k
SPXSDirexion Daily S&P 500 Bear 3X Shares New
US$ 6.10
(0.00%)
95.9M
NVDQT Rex 2X Inverse NVIDIA Daily Target ETF
US$ 2.875
(-7.56%)
88.73M
TSLZT Rex 2X Inverse Tesla Daily Target ETF
US$ 4.14
(7.81%)
88.08M
SOXLDirexion Daily Semiconductor Bull 3X Shares
US$ 26.29
(4.87%)
75.87M
FXIiShares China Large Cap
US$ 36.455
(3.04%)
72.78M

PTN Discussion

View Posts
zeusgodmd zeusgodmd 2 weeks ago
Outcome data by the end of the month per ceo 
👍️0
zeusgodmd zeusgodmd 3 weeks ago
3 drugs coming out the end of there pipeline
👍️0
StocktonCA StocktonCA 3 weeks ago
this Stock is on the move!!! finished Obesity drug study today, results will be released by end of this qquarter. price target $17. no brainer. flying under the radar......
👍️0
tw0122 tw0122 3 weeks ago
PTN .94 +9% ...19m float...


👍️0
StocktonCA StocktonCA 4 weeks ago
HC Wainwright Reaffirms “Buy” Rating for Palatin Technologies (NYSEAMERICAN:PTN)



Posted by MarketBeat News on Jan 30th, 2025





Share on Twitter Share on Facebook Share on LinkedIn

Share on Stocktwits





?Palatin Technologies (NYSEAMERICAN:PTN – Get Free Report)‘s stock had its “buy” rating reissued by stock analysts at HC Wainwright in a research report issued to clients and investors on Tuesday,Benzinga reports. They currently have a $17.00 price objective on the biopharmaceutical company’s stock.

Palatin Technologies Trading Up 0.7 %

NYSEAMERICAN PTN opened at $0.91 on Tuesday. Palatin Technologies has a 1-year low of $0.68 and a 1-year high of $5.22. The stock has a market capitalization of $17.77 million, a PE ratio of -0.46 and a beta of 0.90.

Get Palatin Technologies alerts:

Institutional Trading of Palatin Technologies

Several large investors have recently added to or reduced their stakes in the stock. Virtu Financial LLC purchased a new position in shares of Palatin Technologies in the third quarter valued at $51,000. HB Wealth Management LLC lifted its holdings in Palatin Technologies by 86.3% in the 4th quarter. HB Wealth Management LLC now owns 110,500 shares of the biopharmaceutical company’s stock worth $127,000 after buying an additional 51,200 shares in the last quarter. Finally, XTX Topco Ltd acquired a new position in Palatin Technologies in the 2nd quarter worth $29,000. 11.50% of the stock is currently owned by institutional investors and hedge funds.

👍️0
zeusgodmd zeusgodmd 4 weeks ago
Nice level to buy some
👍️0
zeusgodmd zeusgodmd 4 weeks ago
Still nothing going on with ceo news
👍️0
zeusgodmd zeusgodmd 2 months ago
I don't think she is going to stop this time 
👍️0
zeusgodmd zeusgodmd 2 months ago
Need a company that's going to sell this product 
👍️0
zeusgodmd zeusgodmd 2 months ago
Nice results 
👍️0
zeusgodmd zeusgodmd 3 months ago
Hc wainwright 17$ price target was 75$ still a ways off of these 2 prices but 2 months will see
👍️0
zeusgodmd zeusgodmd 3 months ago
Can't buy big chipmunks of it
👍️0
zeusgodmd zeusgodmd 3 months ago
News any time
👍️0
zeusgodmd zeusgodmd 3 months ago
Meibo eye drops just came out for dry eyes saw commercial 
👍️0
zeusgodmd zeusgodmd 4 months ago
Far off from 17$ though
👍️0
zeusgodmd zeusgodmd 4 months ago
Looking good
👍️0
zeusgodmd zeusgodmd 4 months ago
Let hear about a partnership
👍️0
zeusgodmd zeusgodmd 5 months ago
Let’s go Merck or Pfizer
👍️0
zeusgodmd zeusgodmd 5 months ago
Got mine
👍️0
zeusgodmd zeusgodmd 5 months ago
Loaded thanks for the share price let’s see what happens in the next 6 months
👍️0
zeusgodmd zeusgodmd 5 months ago
Last of the cheapies
👍️0
zeusgodmd zeusgodmd 5 months ago
Wainwright really confident the stock going to see 17$ can’t wait
👍️0
zeusgodmd zeusgodmd 5 months ago
Bottom shot until partners get established
👍️0
zeusgodmd zeusgodmd 5 months ago
I guess it’s the atm for the company or eye drug not approved will see on the first
👍️0
zeusgodmd zeusgodmd 5 months ago
I bought this many shares yesterday
👍️0
zeusgodmd zeusgodmd 5 months ago
Maybe some seller didn’t put a limit on his sell. He won’t do that again
👍️0
zeusgodmd zeusgodmd 5 months ago
Not as easy to get today
👍️0
zeusgodmd zeusgodmd 5 months ago
Cat must be out of the bag
👍️0
Monksdream Monksdream 6 months ago
PTN under $2
👍️0
zeusgodmd zeusgodmd 6 months ago
I got enough for the ride
👍️0
zeusgodmd zeusgodmd 6 months ago
Time to load up
👍️0
Monksdream Monksdream 7 months ago
PTN under $2
👍️0
Monksdream Monksdream 8 months ago
PTN under $2
👍️0
mike1986 mike1986 11 months ago
You may just get your wish. This stock has been making promises for years and now expects everyone to wait until 2025 for any hope of marketing its dry eye ointment, while looking for a partner to do the heavy lifting. Ahhhhhhh..........
👍️0
Stockexpertpro Stockexpertpro 11 months ago
PTN Palatin Announces Phase 3 PL9643 MELODY-1 Dry Eye Disease (DED) Clinical Data Results Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2024

https://finance.yahoo.com/news/palatin-announces-phase-3-pl9643-113000533.html
👍️0
zeusgodmd zeusgodmd 11 months ago
Waiting for 1.25
👍️0
Monksdream Monksdream 11 months ago
PTN under $2
👍️0
mte1955 mte1955 12 months ago
Well just great. Pump it the few days before the announcement and sell it on the news.
👍️0
mike1986 mike1986 1 year ago
I love the way these low cap stocks move up and down on no news.
👍️0
mike1986 mike1986 1 year ago
On the move with high volume. Hope something announced soon.
👍️ 1
mte1955 mte1955 1 year ago
So I guess people are disappointed with the latest report. Nothing new but nothing detrimental either.
👍️0
zeusgodmd zeusgodmd 1 year ago
Did not see that coming. Why can’t they what. Til after the news
👍️0
zeusgodmd zeusgodmd 1 year ago
Guess no news this week
👍️0
zeusgodmd zeusgodmd 1 year ago
There are people here that seem to start buying 3 days before a big announcement but everybody is looking at before the end of the year will see
👍️0
power11 power11 1 year ago
ANY SPECIFIC DATE ???
THANKS
👍️0
zeusgodmd zeusgodmd 1 year ago
News next week
👍️0
zeusgodmd zeusgodmd 1 year ago
Good luck in am. Need a new partner to launch eye sauce. Royalty payments with a down payment. New sex med, new Ibs med why are we at 2$
👍️0
zeusgodmd zeusgodmd 1 year ago
It was going a nice direction why fk it up.
👍️0
mike1986 mike1986 1 year ago
Seems more like unloading today. Buy the rumor, sell the news.
👍️0
zeusgodmd zeusgodmd 1 year ago
Highest volume in over a year will take it. Money managers starting the load
👍️0

Your Recent History

AMEX
PTN
Palatin Technologies
USOTC
LQMT
Liquidmetal Technologies (QB)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads